Active Biotech AB (publ) (ACTI.ST)

SEK 0.08

(-1.72%)

Total Debt Summary of Active Biotech AB (publ)

  • Active Biotech AB (publ)'s latest annual total debt in 2023 was 3 Million SEK , down -50.31% from previous year.
  • Active Biotech AB (publ)'s latest quarterly total debt in 2024 Q3 was - SEK , down -100.0% from previous quarter.
  • Active Biotech AB (publ) reported annual total debt of 6.03 Million SEK in 2022, up 512.37% from previous year.
  • Active Biotech AB (publ) reported annual total debt of 986 Thousand SEK in 2021, down -50.72% from previous year.
  • Active Biotech AB (publ) reported quarterly total debt of - SEK for 2024 Q3, down -100.0% from previous quarter.
  • Active Biotech AB (publ) reported quarterly total debt of 2.3 Million SEK for 2024 Q2, down -11.54% from previous quarter.

Annual Total Debt Chart of Active Biotech AB (publ) (2023 - 2002)

Historical Annual Total Debt of Active Biotech AB (publ) (2023 - 2002)

Year Total Debt Total Debt Growth
2023 3 Million SEK -50.31%
2022 6.03 Million SEK 512.37%
2021 986 Thousand SEK -50.72%
2020 2 Million SEK -38.49%
2019 3.25 Million SEK -98.41%
2018 204.35 Million SEK -2.88%
2017 210.41 Million SEK -2.71%
2016 216.27 Million SEK -2.91%
2015 222.76 Million SEK -2.95%
2014 229.53 Million SEK -0.61%
2013 230.94 Million SEK -2.36%
2012 236.51 Million SEK -2.59%
2011 242.8 Million SEK -5.61%
2010 257.22 Million SEK 0.68%
2009 255.47 Million SEK -1.12%
2008 258.37 Million SEK 1.75%
2007 253.92 Million SEK -29.22%
2006 358.74 Million SEK -0.49%
2005 360.49 Million SEK 266.09%
2004 98.47 Million SEK 1897.4%
2003 4.93 Million SEK 84.02%
2002 2.67 Million SEK 0.0%

Peer Total Debt Comparison of Active Biotech AB (publ)

Name Total Debt Total Debt Difference
Biovica International AB (publ) 7.82 Million SEK 61.676%
Cantargia AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Cyxone AB (publ) 858 Thousand SEK -249.65%
Diagonal Bio AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK -75.336%
Fluicell AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 87.749%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Intervacc AB (publ) 181 Thousand SEK -1557.459%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 95.025%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 231.47 Million SEK 98.704%
Lipum AB (publ) 1.76 Million SEK -70.358%
Alligator Bioscience AB (publ) 16.09 Million SEK 81.363%
Ziccum AB (publ) 857 Thousand SEK -250.058%
BioArctic AB (publ) 4.97 Million SEK 39.747%
Genovis AB (publ.) 79.32 Million SEK 96.218%
Camurus AB (publ) 24.5 Million SEK 87.759%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 89.117%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 40.0%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 91.85%
Kancera AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 95.799%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -607.547%
Karolinska Development AB (publ) 3.07 Million SEK 2.28%
Amniotics AB (publ) 2.58 Million SEK -16.279%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -200.0%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.694%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.654%
Biosergen AB - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 85.445%
Corline Biomedical AB - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -350.45%
LIDDS AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 108.6 Million SEK 97.238%
BioInvent International AB (publ) 23.24 Million SEK 87.093%
SynAct Pharma AB 637 Thousand SEK -370.958%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -252.941%
Alzinova AB (publ) 800 Thousand SEK -275.0%
Ascelia Pharma AB (publ) 1.06 Million SEK -182.752%
Oncopeptides AB (publ) 106.48 Million SEK 97.183%
Pila Pharma AB (publ) 773.08 Thousand SEK -288.058%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 96.694%
Diamyd Medical AB (publ) 30.67 Million SEK 90.219%